Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM): a Single Arm Phase II Study

NCT07237399 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT07237399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07237399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM): a Single Arm Phase II Study
Lead sponsor
University Hospital, Ghent
Phase
Observational
Overall status
Withdrawn
Start date
May 10, 2026
Completion date
April 1, 2031
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ablation techniques, oligometastatic prostate cancer (ompc), prostate cancer (adenocarcinoma)